SES Logo

SYSTEMIC ENZYME SUPPORT.org

 

Pyelonephritis

In a study of 66 patients with chronic pyelonephritis, Wobenzym yielded results that “considerably exceeded those in conventional drug treatment.” This was evidenced by both clinical findings (symptoms) as well as laboratory findings.
One reason for the notable benefit would be due to the normalization of urinary system local immunity, as we just discussed.
Now I will be the first to admit that kidney infections are serious conditions, and antibiotic therapy is very appropriate therapy. But what we have observed is that chronic and recurrent infections – infections that are resistant to improvement even on antibiotics – do much better – and can be resolved when Wobenzym is added to the treatment plan. Other conditions that are often resistance to antibiotic therapy and benefit from this systemic enzyme therapy also include and recurrent urinary tract infections, a very common problem of the urinary system.
                                                    From FREQUENTLY ASKED QUESTIONS, with answers by Joseph J Collins, RN, ND
                                                    Read the special section: KIDNEY AND BLADDER CONDITIONS & WOBENZYM®

What the literature says about Systemic Enzyme Support and:

Pyelonephritis

Clinico-laboratory evaluation of treatment efficacy in chronic pyelonephritis patients with Wobenzym. 

Schved N.I., Martyniuk L.P. Clinico-laboratory evaluation of treatment efficacy in chronic pyelonephritis patients with Wobenzym. Vratschebnaya praktika 1997, 4, 38-42.Ternopol medical academy. [Abstract available in Russian.] 

  Abstract: The influence of Wobenzym on pathogenetic mechanisms of chronic pyelonephritis and its therapeutic effect was observed. The results of treating 66 patients with chronic pyelonephritis were presented. The investigation revealed that Wobenzym enabled to receive positive clinico-laboratory results, which considerably exceeded those in conventional drug treatment. Therapy with Wobenzym resulted improving immunology and rheology blood induce normalising parameters of lipid peroxidation and antioxidant system as well. Key words: chronic pyelonephritis, Wobenzym, immunology, rheology, lipid peroxidation, antioxidant system.
Poster Reference Number 31. 

Coenzyme metabolic assurance of patients with recurrent nephrolithiasis in the complex treatment by systemic enzyme therapy.  

Borisov O.V. Coenzyme metabolic assurance of patients with recurrent nephrolithiasis in the complex treatment by systemic enzyme therapy. Urologia 1998, 3, pp. 29-35. Odessa Medical University, Department of Urology, Odessa, Ukraine. [Abstract available in Ukrainian.]  
 In addition to clinico-immunological investigation, the metabolic supply of enzymatic systems with pyridoxal phosphate and thiamin pyrophosphate was studied in 50 patients with recurrent nephrolithiasis complicated by chronic pyelonephritis. It was established that the value of thiamin pyrophosphate - effect was reliably increased in patients with nephrolithiasis, this witnessing the insufficient metabolic supply with coenzyme form of vitamin B1-cocarboxylase. There was a strong tendency to the growth of pyridoxal phosphate-effect. The complex treatment of patients included antiinflammatory, antibacterial therapy, as well as operative intervention in the upper urinary tract. 25 patients additionally received polyenzyme preparation Phlogenzym in the early postoperative period (for 2-3 weeks) and as out-patients (for 2 weeks more).
The complex treatment of nephrolithic patients with the use of Phlogenzym produced marked normalizing influence on the value of pyridoxal phosphate-effect which is indicative of the reduction of alterations in the urinary tract tissues. The postoperative period had a favourable course, and the control check-up carried out 12 months later revealed that the incidence of lithogeny recurrence was reliably lower than in the control group.
Poster Reference Number 33.